L01BB04 cladribine
ATC group of level 5 – chemical substance · in plain English: cancer medicines that stop cells from dividing
This site has the patient leaflet or the SPC of 2 medicines in this group.
- 1 prescription only (POM)
Active substance: Cladribine – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01B Antimetabolites 182 medicines
- L01BB Purine analogs, antimetabolites antineoplastic 25 medicines
- L01BB04 cladribine 2 medicines
- L01BB Purine analogs, antimetabolites antineoplastic 25 medicines
- L01B Antimetabolites 182 medicines
- L01 Antineoplastic agents 1,025 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Leustat subcutaneous 2 mg/ml solution for injection SPC | – |
| Litak 2 mg/ml solution for injection SPC | Prescription only (POM) |
Other groups of the same level
- L01BB02 mercaptopurine 8 medicines
- L01BB03 tioguanine 1 medicine
- L01BB05 fludarabine 6 medicines
- L01BB06 clofarabine 7 medicines
- L01BB07 nelarabine 1 medicine
Other names of the ATC group
- Czech: L01BB04 Kladribin
- French: L01BB04 cladribine
- German: L01BB04 Cladribin
- Spanish: L01BB04 CLADRIBINA
- German: L01BB04 Cladribin
- Italian: L01BB04 CLADRIBINA
- Polish: L01BB04 KLADRIBIN
- Turkish: L01BB04 kladribin
- Portuguese (Brazil): L01BB04 Cladribina
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01BB04
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.